ロード中...
Halometasone 0.05% Cream in Eczematous Dermatoses
Objective: The authors aimed to document the real-life performance of halometasone 0.05% w/w cream in day-today practice through this multicenter, open-label, Phase 4 study in India. Methods: The authors enrolled 302 eligible patients either with acute or chronic eczema and treated them with halomet...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Matrix Medical Communications
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3848651/ https://ncbi.nlm.nih.gov/pubmed/24307924 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|